Abstract
Cancer immunotherapy with interleukin-2 (IL-2) has demonstrated long term disease control in metastatic renal cell carcinoma and malignant melanoma. With introduction of novel kinase inhibitors, immunomodulatory molecules, cytokines, and vaccines for treatment of cancer there is an increased interest in combining these therapeutic strategies with IL-2. Here we discuss toxicity and established activity of IL-2 in the management of advanced malignancies, and speculate on future use of this cytokine for treatment of cancer.
Keywords: Interleukin-2, kidney cancer, melanoma, immunotherapy, Cancer Therapy, (IL-2), cell carcinoma, malignant melanoma, (IL-2R), phosphorylation, tyrosine kinase, TNF alpha and beta, T-cells, transient fever, lymphopenia, Metastatic Melanoma, Renal Cell Cancer, renal cell carcinoma, IL-2 therapy, HIGH DOSE IL-2, fever, chills, lethargy, diarrhea, nausea, anemia, thrombocytopenia, eosinophilia, hepatic enzymes elevation, erythroderma, confusion, eosinophilic myocarditis, cardiac stress test, (Eastern Coopera-tive Oncology Group Scale, Interferon, tumor infiltrating lymphocytes (TILs), Phase III clinical trial, Phase II clinical trial, biochemotherapy (BCT), Interferon-alpha, inhibitors, metastatic kidney cancer, malig-nant melanoma
Current Medicinal Chemistry
Title: Interleukin 2 in Cancer Therapy
Volume: 17 Issue: 29
Author(s): G. K. Antony and A. Z. Dudek
Affiliation:
Keywords: Interleukin-2, kidney cancer, melanoma, immunotherapy, Cancer Therapy, (IL-2), cell carcinoma, malignant melanoma, (IL-2R), phosphorylation, tyrosine kinase, TNF alpha and beta, T-cells, transient fever, lymphopenia, Metastatic Melanoma, Renal Cell Cancer, renal cell carcinoma, IL-2 therapy, HIGH DOSE IL-2, fever, chills, lethargy, diarrhea, nausea, anemia, thrombocytopenia, eosinophilia, hepatic enzymes elevation, erythroderma, confusion, eosinophilic myocarditis, cardiac stress test, (Eastern Coopera-tive Oncology Group Scale, Interferon, tumor infiltrating lymphocytes (TILs), Phase III clinical trial, Phase II clinical trial, biochemotherapy (BCT), Interferon-alpha, inhibitors, metastatic kidney cancer, malig-nant melanoma
Abstract: Cancer immunotherapy with interleukin-2 (IL-2) has demonstrated long term disease control in metastatic renal cell carcinoma and malignant melanoma. With introduction of novel kinase inhibitors, immunomodulatory molecules, cytokines, and vaccines for treatment of cancer there is an increased interest in combining these therapeutic strategies with IL-2. Here we discuss toxicity and established activity of IL-2 in the management of advanced malignancies, and speculate on future use of this cytokine for treatment of cancer.
Export Options
About this article
Cite this article as:
K. Antony G. and Z. Dudek A., Interleukin 2 in Cancer Therapy, Current Medicinal Chemistry 2010; 17 (29) . https://dx.doi.org/10.2174/092986710793176410
DOI https://dx.doi.org/10.2174/092986710793176410 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?
Cardiovascular & Hematological Agents in Medicinal Chemistry Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Curcumin: Powerful Immunomodulator from Turmeric
Current Immunology Reviews (Discontinued) Clinical Significance of Thiopurine S-Methyltransferase Gene Polymorphisms
Current Pharmacogenomics Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy
Current Drug Targets PEO-PPO Block Copolymers for Passive Micellar Targeting and Overcoming Multidrug Resistance in Cancer Therapy
Current Drug Targets Disorders of Mechanisms of Calcium Metabolism Control as Potential Risk Factors of Prostate Cancer
Current Medicinal Chemistry Pharmacokinetic and Metabolism Determinants of Fluoropyrimidines and Oxaliplatin Activity in Treatment of Colorectal Patients
Current Drug Metabolism mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets Mesenchymal Stem Cells Induced In Vitro Generated Regulatory-T Cells: Potential Soldiers of Transplantation Biology
Current Biotechnology Pharmacological Activities and Therapeutic Potential of Kaempferitrin in Medicine for the Treatment of Human Disorders: A Review of Medicinal Importance and Health Benefits
Cardiovascular & Hematological Disorders-Drug Targets Prediction of Chemical Multi-target Profiles and Adverse Outcomes with Systems Toxicology
Current Medicinal Chemistry Recent Advances in Validating MDM2 as a Cancer Target
Anti-Cancer Agents in Medicinal Chemistry LDH Nanocontainers as Bio-Reservoirs and Drug Delivery Carriers
Recent Patents on Nanotechnology Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies
Current Clinical Pharmacology Diagnostic, Prognostic and Therapeutic Potential of Heat Shock Proteins in Schistosomiasis and Bladder Cancer: A Review
Letters in Drug Design & Discovery Nitroxyl (HNO): A Possible Strategy for Fighting Cancer
Current Topics in Medicinal Chemistry Is there a Role for Bevacizumab in Non-Glial Tumors?
Current Drug Targets Aldosterone and the Pathogenesis of Hypertension
Current Hypertension Reviews The Role of Cytochrome P450 in Herb-Drug Interactions
Current Pharmacogenomics